The Latest Breaking News from talc

Johnson & Johnson Pays $5.5B Over Baby Powder Cancer Claims; Wall Street Rewards It Anyway

Johnson & Johnson's $5.5B talc settlement impacts ovarian cancer claims and stock performance. Learn about the legal outcomes, unresolved issues, and future implications for claimants and investors.

International Business Times UK · Jul 29

Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity

Johnson & Johnson's post-earnings pullback follows a revenue and EPS beat, raised guidance, and analyst price target increases, with talc litigation remaining the key risk to watch.

MarketBeat · Jul 15

NIA arrests two key accused in 3,000-kg Mundra heroin seizure case

One of them smuggled drugs on the Indian side, sold it to domestic traffickers and routed the proceeds to the kingpin in Afghanistan

The Hindu · Aug 25, 2022